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Abstract
Neonatal growth is characterized by a high protein synthesis rate that is largely due to an enhanced sensitivity to
the postprandial rise in insulin and amino acids, especially leucine. The mechanism of leucine’s action in vivo is not
well understood. In this study, we investigated the effect of leucine infusion on protein synthesis in skeletal muscle
and liver of neonatal pigs. To evaluate the mode of action of leucine, we used rapamycin, an inhibitor of
mammalian target of rapamycin (mTOR) complex-1 (mTORC1). Overnight-fasted 7-day-old piglets were treated with
rapamycin for 1 hour and then infused with leucine (400 μmol·kg-1·h-1) for 1 hour. Leucine infusion increased the
rate of protein synthesis, and ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor (eIF) 4E-binding
protein-1 (4E-BP1) phosphorylation in gastrocnemius and masseter muscles (P < 0.05), but not in the liver. The
leucine-induced stimulation of protein synthesis and S6K1 and 4E-BP1 phosphorylation were completely blocked
by rapamycin, suggesting that leucine action is by an mTORC1-dependent mechanism. Neither leucine nor
rapamycin had any effect on the activation of the upstream mTORC1 regulators, AMP-activated protein kinase and
protein kinase B, in skeletal muscle or liver. The activation of eIF2a and elongation factor 2 was not affected by
leucine or rapamycin, indicating that these two pathways are not limiting steps of leucine-induced protein
synthesis. These results suggest that leucine stimulates muscle protein synthesis in neonatal pigs by inducing the
activation of mTORC1 and its downstream pathway leading to mRNA translation.
Keywords: leucine, mTORC1, neonatal pigs, rapamycin, skeletal muscle
Introduction
One of the hallmarks of the neonatal period is rapid
growth, which is due to a high rate of protein synthesis
[1]. We previously showed in neonatal pigs that the high
rate of deposition of proteins, especially in skeletal muscle,
is in part due to their ability to increase protein synthesis
in response to feeding, a response that significantly
declines with development [2]. We further demonstrated
that the feeding-induced stimulation of protein synthesis
in most tissues is independently regulated by insulin and
amino acids [3]. Among amino acids, we found that leu-
cine alone can stimulate protein synthesis in neonatal pigs
and this effect decreases with development [4,5]. However,
the molecular mechanism underlying the effect of leucine
on the stimulation of protein synthesis in vivo is not com-
pletely known.
Mammalian target of rapamycin (mTOR) is a nutri-
ent- and hormone-sensitive kinase that plays a major
role in cell metabolism, including protein synthesis [6,7].
The kinase mTOR exists in two structurally and func-
tionally distinct complexes referred to as mTOR com-
plex 1 (mTORC1) and mTORC2 [6]. Considerable
evidence indicates that mTORC1 is rapamycin sensitive
while mTORC2 is rapamycin insensitive. The main
function of mTORC1 is to regulate mRNA translation
by directly phosphorylating two down-stream substrates,
ribosomal protein S6 kinase 1 (S6K1) and eukaryotic
initiation factor (eIF) 4E-binding protein-1 (4E-BP1).
S6K1 is a kinase for ribosomal protein S6 (rpS6) and its
activation by S6K1 is crucial for mRNA translation.
Furthermore, a phosphorylated form of 4E-BP1 releases
eIF4E from the inactive eIF4E·4E-BP1 complex, allowing
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the formation of the active eIF4G·eIF4E complex to par-
ticipate in translation initiation [8]. The second com-
plex, mTORC2, has been postulated to regulate the
activation of protein kinase B (PKB) [6]. The exact
mechanisms by which nutrients/amino acids, especially
leucine, activate mTORC1 have been partly elucidated
using cell culture systems [9]. Studies using cell cultures
have identified several upstream components, including
PKB and AMP-activated protein kinase (AMPK), which
are involved in mTORC1 activation [10,11]. Eukaryotic
initiation factor 2 and elongation factor 2 (eEF2) path-
ways have also been shown to be affected by amino
acids/leucine [12,13].
Most of the information regarding leucine action on
the mTORC1-dependent stimulation of protein synth-
esis has been generated using cell culture studies [9,14].
Our previous studies have shown that administration of
physiological concentrations of leucine can stimulate
protein synthesis in neonatal pigs by enhancing the acti-
vation of signaling components leading to mRNA trans-
lation [15]. Nevertheless, the molecular mechanism of
leucine-dependent activation of mTORC1, resulting in
enhanced protein synthesis in the neonate, has not been
completely studied. Therefore, our study aimed to deter-
mine the molecular mechanism by which leucine modu-
lates mTORC1 activation and protein synthesis in
skeletal muscle with different fiber types, represented by
gastrocnemius and masseter muscles, and in visceral tis-
sues, represented by the liver, using rapamycin as an
mTORC1 blocker. We hypothesized that the leucine-
induced increase in protein synthesis in skeletal muscle




Multiparous crossbred (Landrace × Yorkshire × Duroc ×
Hampshire) pregnant sows (Agriculture Headquarters,
Texas Dept. of Criminal Justice, Huntsville, TX) were
housed in lactation crates in individual environmentally
controlled rooms before farrowing. Sows were fed a com-
mercial diet (no. 5084, PMI Feeds, Richmond, IN) and pro-
vided water ad libitum. After farrowing, piglets remained
with the sow and were given supplemental creep feed.
Three days before the experiment, piglets were anesthe-
tized for sterile catheter insertion into a jugular vein and
carotid artery. Piglets were then returned to the sow and
allowed to suckle freely until being studied at 7 days of age
(2.0 ± 0.3 kg). This protocol has been previously described
[16] and was approved by the Animal Care and Use Com-
mittee of Baylor College of Medicine. Studies were con-
ducted in accordance with the National Research Council’s
Guide for the Care and Use of Laboratory Animals.
Treatments and infusion
Piglets (n = 23) were fasted for 12 to 14 hours before infu-
sion and placed in a sling restraint system. Pigs were ran-
domly assigned to one of four treatment groups: 1) saline
(control), 2) saline + rapamycin, 3) leucine, and 4) leucine +
rapamycin. Piglets assigned to the rapamycin groups were
injected with a rapamycin solution (0.75 mg/kg in 5%
dimethyl sulfoxide) 1 hour before the initiation of the leu-
cine infusion while other pigs were injected with diluent.
Leucine infusion was initiated with a priming dose (148
μmol/kg) for 10 minutes, followed by a constant infusion of
leucine at 400 μmol·kg-1·h-1 for 1 hour. This infusion rate
was chosen because our previous studies [15] showed that
a two- to three-fold elevation in plasma leucine concentra-
tions, similar to those observed with feeding, was achieved
by this rate of leucine infusion. During the priming and
constant infusion period, saline-infused pigs received a
volume of saline equal to that of those receiving leucine.
Tissue protein synthesis in vivo
Fractional rates of protein synthesis were measured with
a modification of the flooding dose method [2,17]. At 30
minutes before the end of the infusion, pigs were injected
with 10 mL/kg body weight of a flooding dose of pheny-
lalanine (Amersham Biosciences, Piscataway, NJ), which
provided 1.5 mM phenylalanine/kg body weight and 0.5
mCi L-[4-3H]phenylalanine/kg body weight. Samples of
whole blood were taken 5, 15, and 30 minutes after the
injection for measurement of the specific radioactivity of
the extracellular free pool of phenylalanine. Pigs were
killed at 60 minutes, and samples of the gastrocnemius
and masseter muscles and liver were collected, immedi-
ately frozen in liquid nitrogen, and stored at -70°C until
later analysis, as previously described [2].
Protein synthesis (Ks expressed as % protein synthe-
sized in a day) was calculated as Ks (%/day) = [(Sb/Sa) ×
(1,440/t)] × 100, where Sb is the specific radioactivity of
the protein-bound phenylalanine; Sa is the specific radio-
activity of the tissue free phenylalanine for the labeling
period, determined from the value for the animal at the
time of tissue collection, and corrected by the linear
regression of the blood-specific radioactivity of the ani-
mal against time; and t is the time of labeling in minutes.
Previous studies have demonstrated that after a flooding
dose of L-[4-3H]phenylalanine is administrated, the spe-
cific radioactivity of tissue free phenylalanine is in equili-
brium with aminoacyl tRNA specific radioactivity, and
therefore, tissue free phenylalanine is a valid measure of
the tissue precursor pool specific radioactivity [18].
Tissue extraction and immunoblot analysis
Tissue samples were homogenized and centrifuged at
10,000 g for 10 minutes at 4°C. Supernatants were
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diluted in sample buffer, frozen in liquid nitrogen, and
stored at -70°C until analysis. Equal amounts of protein
samples were electrophoretically separated on polyacry-
lamide gels and transferred to a polyvinylidene difluor-
ide membrane (Bio-Rad, Hercules, CA). The membrane
was incubated with appropriate primary antibodies,
washed, and exposed to an appropriate secondary anti-
body as previously described [16].
For normalization, immunoblots performed with anti-
phospho-specific antibodies were stripped in stripping buf-
fer (Pierce Biotechnology, Rockford, IL) and reprobed with
the corresponding non-phospho-specific antibodies. Blots
were developed with an enhanced chemiluminescence kit
(Amersham Biosciences, Piscataway, NJ), visualized, and
analyzed with a ChemiDoc-It Imaging System (UVP,
Upland, CA). Primary antibodies that were used in the
immunoblotting were PKB (total and Ser473; Cell Signaling
Technology, Beverly, MA), AMPK-a (total and Thr172;
Cell Signaling Technology, Beverly, MA), eIF2a (total and
Ser51; Cell Signaling Technology, Beverly, MA), S6K1
(total and Thr398; Cell Signaling Technology, Beverly,
MA), 4E-BP1 (total; Bethyl Laboratories, Montgomery, TX,
and Thr70; Cell Signaling Technology, Beverly, MA), and
eEF2 (total and Thr56; Cell Signaling Technology, Beverly,
MA).
Statistics
All data were analyzed using 2 × 2 factorial analysis. When
a significant overall effect was observed, differences among
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Figure 1 Fractional rates of protein synthesis in gastrocnemius muscle (A), masseter muscle (B) and liver (C) of 7-day-old pigs after 60
minutes of infusion of saline (Sal), saline with rapamycin (Sal+Rap), 400 μmol·kg-1·h-1 leucine without rapamycin (Leu), or 400
μmol·kg-1·h-1 leucine with rapamycin (Leu+Rap). Values are means ± pooled SE; n = 5-7 per treatment. Values with different superscripts
differ significantly (P < 0.05).
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comparisons test. Probability values of P < 0.05 were con-
sidered statistically significant. Data are presented as
means ± SEM.
Results
Protein synthesis in skeletal muscles and liver
Fractional rates of protein synthesis in the gastrocnemius
muscle, which primarily contains glycolytic fibers, and
masseter muscle, primarily containing oxidative fibers,
were enhanced by leucine infusion at physiological levels
(P < 0.05; Figure 1). However, leucine had no effect on pro-
tein synthesis in the liver. In the current study, we wished
to determine whether inhibition of mTORC1 activation by
rapamycin could suppress leucine-induced stimulation of
protein synthesis in neonatal pigs. We found that rapamy-
cin administration completely blocked leucine-induced
protein synthesis in both muscle types (P < 0.05; Figure 1).
Rapamycin administration had no effect on the basal fast-
ing rate of protein synthesis in all tissues determined.
Effect of leucine on the activation of signaling
components upstream and downstream of mTORC1
The molecular mechanisms responsible for the positive
effect of leucine on in vivo protein synthesis are not
completely understood. Therefore, in the current study,
we investigated the effect of leucine on the activation of
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Figure 2 Phosphorylation of PKB in gastrocnemius muscle (A), masseter muscle (B) and liver (C) of 7-day-old pigs after 60 minutes of
infusion of saline (Sal), saline with rapamycin (Sal+Rap), 400 μmol·kg-1·h-1 leucine without rapamycin (Leu), or 400 μmol·kg-1·h-1
leucine with rapamycin (Leu+Rap). Values are means ± pooled SE; n = 5-7 per treatment.
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signaling components leading to protein synthesis. We
determined the activation of PKB and AMPK (upstream
effectors of mTORC1), S6K1 and 4E-BP1 (commonly
used as mTORC1 readouts), and eIF2a and eEF2 (sig-
naling factors crucial for translation initiation and elon-
gation, respectively). In gastrocnemius and masseter
muscles and liver, leucine infusion had no effect on the
phosphorylation of PKB or AMPK (Figures 2 and 3).
Leucine infusion robustly induced the phosphorylation
of S6K1 and 4E-BP1 in gastrocnemius and masseter
muscles, but not in the liver (P < 0.05; Figure 4 and 5).
Blocking the activation of mTORC1 by rapamycin
administration completely inhibited the leucine-induced
phosphorylation of S6K1 and 4E-BP1 (P < 0.05; Figures
4 and 5). Leucine infusion had no effect on the phos-
phorylation of eIF2a and eEF2 in all tissues examined
(Figures 6 and 7).
Discussion
Leucine serves as a precursor for protein synthesis and
also acts as a nutrient signal that regulates protein synth-
esis both in vitro and in vivo [19,20]. A great deal of infor-
mation regarding the molecular mechanism by which
leucine increases protein synthesis has been generated
from cell culture studies [9]. However, information on leu-
cine acting in culture may not be applicable to the situa-
tion in whole animals because of the different types of cell
culture used and the complexity of in vivo environments.
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Figure 3 Phosphorylation of AMPK in gastrocnemius muscle (A), masseter muscle (B) and liver (C) of 7-day-old pigs after 60 minutes
of infusion of saline (Sal), saline with rapamycin (Sal+Rap), 400 μmol·kg-1·h-1 leucine without rapamycin (Leu), or 400 μmol·kg-1·h-1
leucine with rapamycin (Leu+Rap). Values are means ± pooled SE; n = 5-7 per treatment.
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Therefore, we and others have studied the possible
mechanism of the leucine-induced stimulation of protein
synthesis using animal models [15,21].
We have previously demonstrated the ability of leucine
to stimulate protein synthesis in neonatal pigs through the
activation of mTORC1 leading to mRNA translation, but
its effect is less than that of a complete amino acid mix-
ture [15]. We found that acute (1 hour) leucine infusion
enhanced protein synthesis; however, leucine-induced pro-
tein synthesis could not be maintained for 2 hours despite
continued mTORC1 activation [15]. This finding was due
to the leucine-induced fall in amino acid levels because
they were used for protein synthesis [5]. When the fall in
amino acids was prevented, the leucine-induced increase
in protein synthesis was restored. These findings are an
example of the complicated outcomes from in vivo studies
compared with those from cell culture studies.
Although the leucine-induced activation of mTORC1 is
well known, the molecular mechanism underlying this
effect is not completely understood [9,22]. A valuable
tool for studying mTORC1 activation is the use of rapa-
mycin, a well-characterized mTORC1 inhibitor [23]. In a
previous study, we found that rapamycin blocked the
feeding-induced stimulation of protein synthesis in the
liver but the rate of protein synthesis was only attenuated
by 60% in skeletal muscle [24]. In contrast to the pre-
vious feeding study [24], in the current study, we did not
observe any effect of leucine on liver protein synthesis.
One possible explanation for this discrepancy between
studies is the different mode of nutrient administration
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Figure 4 Phosphorylation of S6K1 in gastrocnemius muscle (A), masseter muscle (B) and liver (C) of 7-day-old pigs after 60 minutes of
infusion of saline (Sal), saline with rapamycin (Sal+Rap), 400 μmol·kg-1·h-1 leucine without rapamycin (Leu), or 400 μmol·kg-1·h-1
leucine with rapamycin (Leu+Rap). Values are means ± pooled SE; n = 5-7 per treatment. Values with different superscripts differ significantly
(P < 0.05).
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(enteral feeding vs. parenteral infusion). In the current
study, in skeletal muscle, rapamycin completely blocked
the leucine-induced stimulation of protein synthesis, sug-
gesting that leucine action is solely though the mTORC1
pathway.
PKB and AMPK, upstream signaling components of
mTORC1, can positively (PKB) and negatively (AMPK)
control mTORC1 activation [10,11]. Our previous
research [25] showed that a physiological rise in amino
acids in vivo has no effect on the phosphorylation of
PKB and AMPK in skeletal muscle of neonatal pigs,
indicating that amino acid-induced activation of
mTORC1 is independent of these signaling components.
In the current study, we found that leucine did not sti-
mulate the phosphorylation of PKB in skeletal muscle
and liver. Our finding is in agreement with others who
showed similar observations in human skeletal muscle
[26] and rat skeletal muscle [27]. However, there are
conflicting results among studies regarding leucine’s
effect on AMPK activation. In a cell culture study [28],
leucine treatment decreased the phosphorylation of
AMPK in C2C12 myoblasts. In contrast, in isolated rat
muscle, leucine failed to affect the phosphorylation of
AMPK [29]. Our recent in vivo study demonstrated that
infusion of physiological levels of leucine does not affect
the phosphorylation of AMPK in skeletal muscle of
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Figure 5 Phosphorylation of 4E-BP1 in gastrocnemius muscle (A), masseter muscle (B) and liver (C) of 7-day-old pigs after 60 minutes
of infusion of saline (Sal), saline with rapamycin (Sal+Rap), 400 μmol·kg-1·h-1 leucine without rapamycin (Leu), or 400 μmol·kg-1·h-1
leucine with rapamycin (Leu+Rap). Values are means ± pooled SE; n = 5-7 per treatment. Values with different superscripts differ significantly
(P < 0.05).
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neonatal pigs [30]. Similarly, in this study, leucine had
no effect on the phosphorylation of AMPK in skeletal
muscle and liver.
Genetic and biochemical evidence strongly support
that S6K1 and 4E-BP1 play pivotal roles as mTORC1
substrates responsible for stimulating protein synthesis
by controlling the step of translation initiation involving
the binding of mRNA to 40S ribosomal subunits [8]. In
the current study, we found that leucine enhanced the
phosphorylation of S6K1 and 4E-BP1 in both skeletal
muscles, and that this effect was completely blocked by
rapamycin administration. These results clearly indicate
that leucine activation of both signaling components is
wholly mediated by mTORC1. Consistent with the lack
of response of liver protein synthesis, leucine did not
affect the phosphorylation of S6K1 and 4E-BP1 in the
liver of neonatal pigs.
Amino acids have been shown to be involved in the
regulation of the eIF2 pathway, a rate limiting step in
translation initiation [12]. In this pathway, eIF2 facili-
tates the association of initiator methionyl-tRNAi (Met-
tRNAi) with the 40S ribosomal subunit, an absolute
requirement for the initiation of translation [12]. Two
factors are recognized in this pathway, eIF2a (inhibitor)
and eIF2B (activator). Under cell stress, such as amino
acid starvation, a kinase for eIF2a, called general control
nonrepressed 2 (GCN2), is activated, resulting in the
phosphorylation of eIF2a. In the phosphorylated state,
eIF2a acts as potent inhibitor of eIF2B. Conversely,
under amino acid-rich conditions, GCN2 activation is
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Figure 6 Phosphorylation of eIF2a in gastrocnemius muscle (A), masseter muscle (B) and liver (C) of 7-day-old pigs after 60 minutes
of infusion of saline (Sal), saline with rapamycin (Sal+Rap), 400 μmol·kg-1·h-1 leucine without rapamycin (Leu), or 400 μmol·kg-1·h-1
leucine with rapamycin (Leu+Rap). Values are means ± pooled SE; n = 5-7 per treatment.
Suryawan et al. Journal of Animal Science and Biotechnology 2012, 3:3
http://www.jasbsci.com/content/3/1/3
Page 8 of 10
suppressed. This enables eIF2B to promote the forma-
tion of the Met-tRNAi-40S ribosomal subunit complex
and to initiate mRNA translation (12. In our study, leu-
cine had no effect on the phosphorylation of eIF2a in
both the liver and skeletal muscle.
Studies using cell cultures have identified a positive
role of leucine in the regulation of the peptide-chain
elongation process, which is regulated by the eEF2 path-
way [31]. In this pathway, the phosphorylation of eEF2,
which results in suppression of the elongation process,
is tightly regulated by eEF2 kinase [13]. Insulin or
amino acid-induced activation of mTOR/S6K1 signaling
causes inactivation of this eEF2 kinase, followed by
dephosphorylation of eEF2. Anabolic stimuli decrease
eEF2 phosphorylation, enabling the elongation process
to occur [14]. Interestingly, in contrast to cell culture
studies, our data showed that leucine did not have any
effect on phosphorylation of eEF2. This finding suggests
that the elongation process is not a rate limiting step in
the leucine-induced stimulation of protein synthesis in
skeletal muscle of neonatal pigs.
In summary, our study results show that leucine can
stimulate protein synthesis in skeletal muscle of neona-
tal pigs. The inability of leucine to enhance protein
synthesis in the liver is probably due to the provision of
leucine parenterally, rather than enterally, to the animal.
Another possibility is that a higher leucine level is
required to induce liver protein synthesis. Our results
also strongly support the notion that the leucine-
induced stimulation of protein synthesis is mTORC1-
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Figure 7 Phosphorylation of eEF2 in gastrocnemius muscle (A), masseter muscle (B) and liver (C) of 7-day-old pigs after 60 minutes of
infusion of saline (Sal), saline with rapamycin (Sal+Rap), 400 μmol·kg-1·h-1 leucine without rapamycin (Leu), or 400 μmol·kg-1·h-1
leucine with rapamycin (Leu+Rap). Values are means ± pooled SE; n = 5-7 per treatment.
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dependent, which is consistent with the findings from in
vitro studies. In conclusion, leucine administration has a
potential role in enhancing growth of neonatal animals.
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